Top Markets
#1 Black Phoenix Black Phoenix +17,849.79%
#2 Cash Dog in Hood Cash Dog in Hood +6,497.44%
#3 AgentFun.AI AgentFun.AI +54.83%
#4 up up +51.83%
#5 Arrow Arrow +50.00%
#6 Quai Network Quai Network +39.61%
#7 Octra Octra +37.18%
#8 Derive Derive +34.26%
#9 B3 (Base) B3 (Base) +29.84%
#10 Block Street Block Street +28.94%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Classifica tra le azioni #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Prezzo delle azioni
$4.66
Capitalizzazione di mercato
$43.92M
Variazione (1 giorno)
-0.63%
Variazione (1 anno)
338.04%
Paese
FR
Scambia Theranexus Société Anonyme (ALTHX)

Categoria

Healthcare
Rapporto P/S per Theranexus Société Anonyme (ALTHX)
Rapporto P/S al July 2026 TTM: 38.28
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Theranexus Société Anonyme, il rapporto P/S attuale (TTM) è 38.28. Alla fine del 2023, era pari a 29.32.
Storico del rapporto P/S per Theranexus Société Anonyme da 2015 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 38.28 1,672.34%
2024 2.16 -92.63%
2023 29.32 30.81%
2022 22.42 -99.94%
2021 40.48K 15,636.51%
2020 257.27 1,228.70%
2019 19.36 -96.16%
2018 503.88 58.16%
2017 318.60 108.08%
2016 153.11 519.84%
2015 24.70 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.26 -88.86%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.29 -73.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.31 -88.75%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.44 -83.17%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.96 -55.70%
NL